Results 321 to 330 of about 569,433 (400)

Application of Syndromic Panels for respiratory Tract Infections in Lung Transplantation: A Critical Review on Current Evidence and Future Perspectives

Transplant Infectious Disease, EarlyView.
Limited data on syndromic panels for detecting respiratory tract infections in lung transplant candidates and recipients are available. While these panels provide a rapid turnaround time, they may fail to identify specific pathogens relevant in this setting, such as fungi.
Andrea Lombardi, Giulia Renisi, Arianna Liparoti, Chiara Bobbio, Alessandra Bandera   +4 more
wiley   +1 more source

Severe acute respiratory syndrome coronavirus 2 infection unevenly impacts metabolism in the coronal periphery of the lungs. [PDF]

iScience
Laro J, Xue B, Zheng J, Ness M, Perlman S, McCall LI.   +5 more
europepmc   +1 more source

Air Filtration and Severe Acute Respiratory Syndrome Coronavirus 2

, 2020
Yevgen Nazarenko
openalex   +1 more source

Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study

Transplant Infectious Disease, EarlyView.
Use of POCtmPCR with noninvasive samples (NPS and sputum) in LTx recipients with viral LRTI are a viable alternative to invasive BAL sampling, ABSTRACT Background Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx).
Susanne Simon, Merle Sophie Kaiser, Marcus Bachmann, Gérard Krause, Jens Gottlieb   +4 more
wiley   +1 more source

A Case Report of a Boy With Clinically Mild Encephalopathy and a Reversible Splenial Lesion Associated With Severe Acute Respiratory Syndrome-Coronavirus 2 Infection. [PDF]

Cureus
Moriuchi Y, Fuchigami T, Morioka I.
europepmc   +1 more source

Respiratory Viruses at Time of Lung Transplant and the Relationship to Primary Graft Dysfunction

Transplant Infectious Disease, EarlyView.
Primary graft dysfunction (PGD) is a form of severe and immediate post‐transplant lung injury that can lead to death. In our cohort of 229 patients undergoing lung transplantation with protocolized day 1 bronchoscopy specimens sent for respiratory viruses (RVs), RV+ status was not associated with an adjusted difference in the risk of PGD.
Laura van den Bosch, Karina Kaur, Rhea Varughese, Alim Hirji, Jason Weatherald, Justin Weinkauf, Dale Lien, Oscar Fernandez Garcia, Carlos Cervera Alvarez, Karen Doucette, Dima Kabbani, Kieran Halloran   +11 more
wiley   +1 more source

Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS). [PDF]

J Infect Dis
Cortier T, Gilboa M, Layan M, Joseph G, Meltzer L, Amit S, Rubin C, Lustig Y, Alroy-Preis S, Kreiss Y, Cauchemez S, Regev-Yochay G.   +11 more
europepmc   +1 more source

Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant Recipients

Transplant Infectious Disease, EarlyView.
In this large study, we demonstrated that a high ISI is independently associated with HCoV LRI in HCT recipients. HCoV LRI was associated with several adverse outcomes such as ICU admission, oxygen requirement, and mortality. The ISI potentially may be used to identify high‐risk HCT recipients with HCoV infections.
Fareed Khawaja, Terri Lynn Shigle, Layale Yaghi, May Daher, Jeremy L. Ramdial, Ella Ariza‐Heredia, Ying Jiang, Roy F. Chemaly   +7 more
wiley   +1 more source

Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. [PDF]

J Infect Dis
Baum HE, Santopaolo M, Francis O, Milodowski EJ, Entwistle K, Oliver E, Hitchings B, Diamond D, Thomas AC, Mitchell RE, Kibble M, Gupta K, Di Bartolo N, Klenerman P, Brown A, Morales-Aza B, Oliver J, Berger I, Toye AM, Finn A, Goenka A, Davidson AD, Ring S, Molloy L, Lewcock M, Northstone K, Roth F, Timpson NJ, Wooldridge L, Halliday A, Rivino L.   +30 more
europepmc   +1 more source

SARS‐CoV‐2 convalescent plasma for the controlled clinical trial “COVIC‐19”: Experience from collection of very high‐titer plasma from superimmunized individuals

Transfusion, EarlyView.
Abstract Background COVID‐19 convalescent plasma (CCP) is a treatment option for COVID‐19. Understanding of donor and product characteristics is important for optimization of CCP therapy. We report the experience of collection of very high‐titer CCP for the trial “A randomized open‐label trial of early, very high‐titer convalescent plasma therapy in ...
Simone Hoffmann, Alina Seidel, Carolin Ludwig, Christiane Vieweg, Rebecca Müller, Henrike Hofmann, Bernd Jahrsdörfer, Patrick Wuchter, Harald Klüter, Michael Schmidt, Matthias Johnsen, Thomas Burkhardt, Thomas Appl, Eva Schrezenmeier, Jan Münch, Pierre Tiberghien, Hubert Schrezenmeier, Sixten Körper   +17 more
wiley   +1 more source